| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.078 | 0.8 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |